Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « AbsEn.i » - entrée « december »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
deceased < december < decent  Facettes :

List of bibliographic references indexed by december

Number of relevant bibliographic references: 120.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000022 (2021) E. Díaz [Espagne] ; R. Amézaga Menéndez [Espagne] ; P. Vidal Cortés [Espagne] ; M G Escapa [Espagne] ; B. Suberviola [Espagne] ; A. Serrano Lázaro [Espagne] ; P. Marcos Neira [Espagne] ; M. Quintana Díaz [Espagne] ; M. Catalán González [Espagne][Pharmacological treatment of COVID-19: Narrative review of the Working Group in Infectious Diseases and Sepsis (GTEIS) and the Working Groups in Transfusions and Blood Products (GTTH)].
000029 (2021) Maurizio Koch[2020: Evidence-Based Medicine odyssey. The fall and rise of evidence-based medicine in the year of coronavirus.]
000035 (2021) L. Anedda [Italie] ; L. Bianchini ; L. Cuzzolin ; G. Finco ; V. Fanos ; M A MarcialisWhat if COVID-19 affects the child: which weapons and how to use them.
000051 (2021) Tahani Bin Ali ; Ghaleb Elyamany ; Maha Nojoom ; Mohamed Alfaki ; Hassan Alahmari ; Abdulwahab Alharthi ; Muwaffak Hijazi ; Atif Alsahari ; Fahad Alabbas ; Abdulnasir Al-Otaibi [Arabie saoudite]Unusual presentation of COVID-19 in a child complicated by massive acute pulmonary embolism and lung infarction.
000062 (2021) Mohamed A. Taha [États-Unis, Égypte] ; Christian A. Hall [États-Unis] ; Colin J. Shortess [États-Unis] ; Richard F. Rathbone [États-Unis] ; Henry P. Barham [États-Unis]Treatment Protocol for COVID-19 Based on T2R Phenotype.
000077 (2021) Muhammad Sani Ismaila [Trinité-et-Tobago] ; Faruku Bande [Nigeria] ; Aminu Ishaka [Nigeria] ; Aminatu Abubakar Sani [Nigeria] ; Karla Georges [Trinité-et-Tobago]Therapeutic options for COVID-19: a quick review.
000107 (2021) O O Oleribe [Nigeria] ; P. Oskouipour [États-Unis] ; O. Nwanyanwu [États-Unis] ; S D Taylor-Robinson [Royaume-Uni]The COVID-19 era: the view from Nigeria.
000137 (2021) Ça La Begüm Apayd N [Turquie] ; Gözde Ç Nar [Turquie] ; Gökçe Cihan-Üstünda [Turquie]Small-molecule antiviral agents in ongoing clinical trials for COVID-19.
000146 (2021) Rahul Sharma [Inde] ; Dharmendra Khokhar [Inde] ; Bhanushree Gupta [Inde] ; Purnendu Saxena [Inde] ; Kallol Kumar Ghosh [Inde] ; Arvind Kumar Geda [Inde] ; Kamil KucaSevere Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2): A Review on Pathophysiology, Diagnosis and Investigational Therapeutics.
000153 (2021) Kavita Manchanda [Inde] ; Jasbir Singh [Inde] ; Ranjeev Bhagat [Inde] ; Ilmjot Kaur Tiwana [Inde] ; Harmanjit Singh [Inde]Safety of pharmacological options for the management of COVID-19 in pregnant women: An Indian perspective.
000170 (2021) Filipa Silva [Portugal] ; Ana Cipriano [Portugal] ; Hugo Cruz [Portugal] ; Joana Tavares [Portugal] ; Joana Fragoso [Portugal] ; Jorge Malheiro [Portugal] ; Manuela Almeida [Portugal] ; La Salete Martins [Portugal] ; Miguel Abreu [Portugal] ; Sofia Pedroso [Portugal] ; Leonídio Dias [Portugal] ; Ant Nio Castro Henriques [Portugal]SARS-CoV-2 infection in kidney transplant recipients: Early report of five cases.
000191 (2021) Dhruva Sharma [Inde] ; Neha Sharma [Inde] ; Preksha Sharma [Inde] ; Ganapathy Subramaniam [Inde]Review of investigational drugs for coronavirus disease 2019.
000299 (2021) Marko Boban [Croatie]Novel coronavirus disease (COVID-19) update on epidemiology, pathogenicity, clinical course and treatments.
000314 (2021) Kauê Francisco Corrêa Souza E Souza [Brésil] ; Bianca Portugal Tavares Moraes [Brésil] ; Izabel Christina Nunes De Palmer Paixão [Brésil] ; Patrícia Burth [Brésil] ; Adriana Ribeiro Silva [Brésil] ; Cassiano Felippe Gonçalves-De-Albuquerque [Brésil]Na+/K+-ATPase as a Target of Cardiac Glycosides for the Treatment of SARS-CoV-2 Infection.
000317 (2021) Masashi Ohe [Japon] ; Ken Furuya [Japon] ; Houman Goudarzi [Japon]Multidrug treatment for COVID-19.
000326 (2021) C N Prashantha [Inde] ; K. Gouthami [Inde] ; L. Lavanya [Inde] ; Sivaramireddy Bhavanam [Inde] ; Ajay Jakhar [Inde] ; R G Shakthiraju [Inde] ; V. Suraj [Inde] ; K V Sahana [Inde] ; H S Sujana [Inde] ; N M Guruprasad [Inde] ; R. Ramachandra [Inde]Molecular screening of antimalarial, antiviral, anti-inflammatory and HIV protease inhibitors against spike glycoprotein of coronavirus.
000349 (2021) Gaber El-Saber Batiha [Égypte] ; Marwa A. Zayed [Égypte] ; Aya A. Awad [Égypte] ; Hazem M. Shaheen [Égypte] ; Suleiman Mustapha [Nigeria] ; Oscar Herrera-Calderon [Pérou] ; Jorge Pamplona Pagnossa [Brésil] ; Abdelazeem M. Algammal [Égypte] ; Muhammad Zahoor [Pakistan] ; Achyut Adhikari [Népal] ; Ishan Pandey [Inde] ; Sara T. Elazab [Égypte] ; Kannan R R. Rengasamy [Afrique du Sud] ; Natália Cruz-Martins [Portugal] ; Helal F. Hetta [Égypte]Management of SARS-CoV-2 Infection: Key Focus in Macrolides Efficacy for COVID-19.
000492 (2021) Reshma Golamari [États-Unis] ; Neeru Kapoor [Inde] ; Tanuja Devaraj [États-Unis] ; Nitasa Sahu [États-Unis] ; Courtney Kramer [États-Unis] ; Rohit Jain [États-Unis]Experimental therapies under investigation for COVID-19.
000569 (2021) Serap Yalç N [Turquie] ; Seda Yalç Nkaya [Turquie] ; Fahriye Ercan [Turquie]Determination of Potential Drug Candidate Molecules of the Hypericum perforatum for COVID-19 Treatment.
000576 (2021) Tobias Welte [Allemagne] ; Lucy J. Ambrose [Royaume-Uni] ; Gillian C. Sibbring [Royaume-Uni] ; Shehla Sheikh [Royaume-Uni] ; Hana Müllerová [Royaume-Uni] ; Ian Sabir [Royaume-Uni]Current evidence for COVID-19 therapies: a systematic literature review.
000603 (2021) Hao-Yu Wu [Taïwan] ; Chien-Ting Pan [Taïwan] ; Chiao-Feng Cheng [Taïwan] ; Chi-Ying Lin [Taïwan] ; Sheng-Nan Chang [Taïwan] ; Yi-Chung Chen [Taïwan] ; Chih-Yuan Wang [Taïwan] ; Yen-Fu Chen [Taïwan] ; Chung-Yu Chen [Taïwan] ; Matthew Huei-Ming Ma [Taïwan] ; Juey-Jen Hwang [Taïwan]Combined intravenous immunoglobulin and baricitinib treatment for severe COVID-19 with rhabdomyolysis: A case report.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "december" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "december" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    december
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021